Apr 1 2024 |
Biden vs. Trump: High Stakes for Cannabis Policy? |
Bradley Arant Boult Cummings LLP |
Apr 1 2024 |
Dictionaries and the Law – Hunting, Poaching, and the Right to Food |
Pierce Atwood LLP |
Mar 29 2024 |
Michigan and West Virginia Propose Unpasteurized, Raw Milk Bills |
Keller and Heckman LLP |
Mar 29 2024 |
Cosmetics and “Forever Chemicals” |
ArentFox Schiff LLP |
Mar 29 2024 |
FDA Releases Final Guidance on New Dietary Ingredient Notification Procedures and Timeframes |
McDermott Will & Schulte LLP |
Mar 29 2024 |
CRS Publishes Report on Regulation of Gene-Edited Plants and Issues for Congress |
Bergeson & Campbell, P.C. |
Mar 28 2024 |
PFAS Drinking Water Rule Clears White House: Let the Litigation Begin |
CMBG3 Law |
Mar 28 2024 |
Same Product in Different Packaging May Constitute Separate Market for Antitrust Purposes |
McDermott Will & Schulte LLP |
Mar 28 2024 |
Texas Regulators to Consider Changes to Consumable Hemp Program |
Bradley Arant Boult Cummings LLP |
Mar 28 2024 |
EC Publishes Communication on Biotechnology and Biomanufacturing, Announces Targeted Actions |
Bergeson & Campbell, P.C. |
Mar 27 2024 |
New Biden Executive Order Emphasizes Women’s Health |
Mintz |
Mar 27 2024 |
Federal Circuit Applies Safe Harbor to Imported Medical Device Samples |
Foley & Lardner LLP |
Mar 27 2024 |
FTC Releases Report on Infant Formula Market |
Keller and Heckman LLP |
Mar 27 2024 |
Arizona Attorney General Deems Delta-8 and Delta-10 Controlled Substances in Controversial Opinion |
Bradley Arant Boult Cummings LLP |
Mar 27 2024 |
Connecticut Appellate Court Rules Employer Could Discharge Medical Marijuana User Impaired on the Job |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Mar 26 2024 |
CODEX ALIMENTARIUS: Outcome of 28th Codex Committee on Fats and Oils (CCFO28) |
Keller and Heckman LLP |
Mar 26 2024 |
Recent Bankruptcy Court Decision Leaves the Door Open to Bankruptcy Relief for Those in the Cannabis Industry |
Mintz |
Mar 26 2024 |
Effective April 1, California’s ‘Fast Act’ Covers More Than ‘Fast Food,’ Comes with Significant Implications |
Greenberg Traurig, LLP |
Mar 26 2024 |
Gerber Explains Vitamin C Not Used as a Preservative in Baby Snacks |
Keller and Heckman LLP |
Mar 26 2024 |
Last Call for Comments on the Bipartisan Discussion Draft of the SUSTAIN Act: Shaping 340B for the Future |
Epstein Becker & Green, P.C. |
Mar 26 2024 |
Delta’s Rough Waters: Attorneys General Call for Regulation of ‘Intoxicating Hemp Products’ |
Norris McLaughlin P.A. |
Mar 26 2024 |
Court Clarifies Employers’ Rights Under Connecticut’s Palliative Use of Marijuana Act, Guidance on Drug Testing |
Epstein Becker & Green, P.C. |
Mar 26 2024 |
President Biden Announces New Price Fixing “Strike Force”: Government Continues Antitrust Crusade |
Proskauer Rose LLP |
Mar 25 2024 |
OECD Issues Report on First WPMN Workshop on NanoCarriers |
Bergeson & Campbell, P.C. |
Mar 25 2024 |
Pardon? Massachusetts Cannabis Offenders Given New Hope |
Bradley Arant Boult Cummings LLP |
Mar 25 2024 |
The Price Is “Wrong”: SEC Sanctions Pharma Company for Faulty Rebates |
Norris McLaughlin P.A. |
Mar 25 2024 |
PFAS in Food Packaging: The Beginning of the End? |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 22 2024 |
Pennsylvania Proposes to Ban Certain Food Additives |
Keller and Heckman LLP |
Mar 22 2024 |
HHS and FDA Seek Comments on Informed Consent Draft Guidance |
McDermott Will & Schulte LLP |
Mar 22 2024 |
NNI Will Hold Webinar on Metrology of Nanoparticles in Electronics on April 5, 2024 |
Bergeson & Campbell, P.C. |
Mar 22 2024 |
Duplicating with Digital Twins: Two Peas in a Pod One Real, One Virtual |
Nishith Desai Associates |
Mar 22 2024 |
A Moving Target: Recent New Jersey Case Shows Changing Laws Complicate Cannabis Business |
Norris McLaughlin P.A. |
Mar 21 2024 |
FDA Announces End of PFAS Use in US Food Packaging |
Squire Patton Boggs (US) LLP |
Mar 21 2024 |
FDA Publishes Paper Detailing Actions It Intends to Take Regarding the Uses of AI Across the Medical Product Life Cycle |
Nelson Mullins |
Mar 21 2024 |
Specially Convened Rehearing Panel Vacates IPR Institution Denial |
McDermott Will & Schulte LLP |